Therefore, targeting SOX2 can potentially reduce cancer cell self-renewal capacity and enhance the effectiveness of cancer treatments; however, little progress has been made due to the difficulty in directly targeting transcription factors [27]. This evidence concerns the gene SOX2 and cancer.